+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-06-11Number of Pages: 123

Healthcare CMO Market Pharmaceutical Contract Manufacturing (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Formulations (FDF) Manufacturing and Packaging) & Medical Device Contract Manufacturing (Design Outsourcing, Device Manufacturing & Final Goods Assembly) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

In the global pharmaceutical and biotechnology industry, outsourcing market represents one of the fastest growing markets and contract manufacturing of pharmaceutical and medical devices occupies a significant portion in the overall outsourcing market. In the past, pharmaceutical and medical device industry has maintained a low level of outsourcing due to several concerns such as product quality, delay in delivery, regulatory compliance and intellectual property protection rights. However, in recent years, outsourcing strategy has become more striking, as the pharmaceutical and medical device companies are looking for various strategic options to reduce cost, improve product portfolio, reduce the time to market and improve efficiencies. Along with these, economic burden, increased financial crisis and technological advances are the other factors that have compelled pharmaceutical, biotechnology and life science companies to outsource their manufacturing processes in order to achieve their cost benefits and save time. 
 
The global healthcare CMO market is segmented into pharmaceutical contract manufacturing services and medical devices contract manufacturing services. Further, the pharmaceutical contract manufacturing services segment is classified as API (active pharmaceutical ingredients) manufacturing, FDF (final dosage formulations) manufacturing and packaging. Among these, contract FDF manufacturing segment is expected to experience a healthy growth rate during the forecast period of 2013 to 2019, due to the rise demand for generic drugs and increasing R&D investment by life sciences companies. In addition, rise in number of blockbuster drugs going off-patent and increased adoption of novel technologies are further boosting the growth of this market. Similarly, medical devices contract manufacturing services segment is further categorized into design outsourcing, device manufacturing and final goods assembly. Among these afore-mentioned services, the market for medical device contract manufacturing accounted for largest market share (87.7%) in 2012 and is expected to grow at an attractive growth rate during the forecast period of 2013 to 2019.
 
Geographically, North America constituted the largest market in the global healthcare CMO market in 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of 17.8% from 2013 to 2019. This growth has been attributed to favorable government regulations, improved intellectual property protection rights and increased adoption of novel technologies. In addition, tax benefits, low labor costs and other overheads and availability of skilled professionals at a very low cost compared to developed nations would trigger the growth of this market in Asia-Pacific region.
 
The major players of this market are Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Lonza Group, Patheon, Inc., Piramal Healthcare, Accellent, Symmetry Medical, Inc., Greatbatch, Inc., Memry Corporation, Teleflex MedOEM, Admedes Schuessler and Donatelle.

 
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Healthcare CMO Market (2012 & 2019)
2.2 Global Healthcare CMO Market, by Service Type, 2012 (USD Billion)
2.3 Global Pharmaceutical Contract Manufacturing Market, by Service Type, 2012 (USD Billion)
2.4 Global Medical Device Contract Manufacturing Market, by Service Type,  2012 (USD Billion)
2.5 Comparative Analysis: Global Healthcare CMO Market, by Geography, 2012 and 2019 (Value %)
 
Chapter 3 Market Overview
3.1 Introduction
3.2 Market Dynamics
      3.2.1 Market Drivers
               3.2.1.1 Patent expirations of drugs are assisting the growth of global CMO industry
                          3.2.1.1.1 List of top brands with patent expirations
               3.2.1.2 Restructuring of pharmaceutical and medical device manufacturing activities augmenting the growth of CMOs market
               3.2.1.3 Increasing trend of outsourcing manufacturing activities from high to low cost regions
               3.2.1.4 Outsourcing to maximize revenue by reducing time to market
      3.2.2 Market Restraints
               3.2.2.1 Quality concerns and non-compliance of regulatory requirements hamper the growth of CMOs market
               3.2.2.2 Failure to deliver on-time supplies
      3.2.3 Opportunities
               3.2.3.1 Biologics
               3.2.3.2 Emerging markets
3.3 Porters Five Forces Analysis: Global Healthcare CMO Market
      3.3.1 Bargaining Power of Suppliers
      3.3.2 Bargaining Power of Buyers
      3.3.3 Threat of New Entrants
      3.3.4 Threat of Substitutes
      3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis: Global Healthcare CMO Market, by Geography
3.5 Heat Map Analysis: Medical Devices Contract Manufacturing Market, by Key Market Players
      3.5.1 Heat Map Analysis: Key Market Players for the Medical Devices Contract Manufacturing Market
3.6 Market Share Analysis: Global Pharmaceutical Contract Manufacturing Market, by Key Players, 2012 (Value %)
 
Chapter 4 Global Healthcare CMO Market, by Service Type
4.1 Introduction
      4.1.1 Global Healthcare CMO Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
4.2 Pharmaceutical Contract Manufacturing Services
      4.2.1 Global Pharmaceutical Contract Manufacturing Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
      4.2.2 Active Pharmaceutical Ingredients (API) Manufacturing
               4.2.2.1 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
      4.2.3 Final Dosage Form (FDF) Manufacturing
               4.2.3.1 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
               4.2.3.2 Solid Dose Formulations
                          4.2.3.2.1 Global Solid Dose Formulations Contract Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
               4.2.3.3 Semi-solid and Liquid Dose Formulations
                          4.2.3.3.1 Global Semi-solid and Liquid Dose Formulations Contract Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.3.4 Injectable Dose Formulations
                          4.2.3.4.1 Global Injectable Dose Formulations Contract Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
      4.2.4 Packaging
              4.2.4.1. Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion)
4.3 Medical Device Contract Manufacturing Services
      4.3.1 Global Medical Device Contract Manufacturing Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
      4.3.2 Outsourcing Design
              4.3.2.1 Global Medical Device Design Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
      4.3.3 Device Manufacturing
              4.3.3.1 Global Device Contract Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
              4.3.3.2 Material Process Services
                         4.3.3.2.1 Global Contract Material Process Services Market Revenue, 2011 – 2019 (USD Billion)
              4.3.3.3 Electronic Manufacturing Services
                         4.3.3.3.1 Global Contract Electronic Manufacturing Services Market Revenue, 2011 – 2019 (USD Billion)
              4.3.3.4 Finished Products
                         4.3.3.4.1 Global Contract Finished Products Manufacturing Services Market Revenue, 2011 – 2019 (USD Billion)
      4.3.4 Final Goods Assembly
              4.3.4.1 Global Contract Final Goods Assembly Services Market Revenue, 2011 – 2019 (USD Billion)
 
Chapter 5 Global Healthcare CMO Market, by Geography
5.1 Overview
      5.1.1 Global Contract Manufacturing Organizations (CMO) Market Revenue, by Geography, 2011 – 2019 (USD Billion)
5.2 North America
      5.2.1 North America Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
      5.2.2 North America Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
      5.2.3 North America Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
5.3 Europe
      5.3.1 Europe Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
      5.3.2 Europe Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
      5.3.3 Europe Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
5.4 Asia Pacific
      5.4.1 Asia-Pacific Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
      5.4.2 Asia-Pacific Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
      5.4.3 Asia-Pacific Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
5.5 RoW
      5.5.1 RoW Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
      5.5.2 RoW Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
      5.5.3 RoW Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
 
Chapter 6 Recommendations
6.1 Success Strategies
      6.1.1 Expand Market in Emerging Countries
      6.1.2 Timely Entry in the Market
      6.1.3 Offer Wide Range of Manufacturing Services
      6.1.4 Developing Strategic Alliances and Partnerships with Pharmaceutical Companies
      6.1.5 Ensure Product Quality, Data Confidentiality and Regulatory Compliance
 
Chapter 7 Company Profiles
7.1 Accellent, Inc.
      7.1.1 Company Overview
      7.1.2 Financial Overview
      7.1.3 Product Portfolio
      7.1.4 Business Strategies
               7.1.4.1 Strategic acquisition
               7.1.4.2 Geographical expansion
      7.1.5 Recent Developments
7.2 Boehringer Ingelheim GmbH
      7.2.1 Company Overview
      7.2.2 Financial Overview
      7.2.3 Product Portfolio
      7.2.4 Business Strategies
               7.2.4.1 Research and development for medical innovation
      7.2.5 Recent Developments
7.3 Catalent Pharma Solutions, Inc.
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Product Portfolio
      7.3.4 Business Strategies
               7.3.4.1 Geographical expansion of business
               7.3.4.2 Diversification of product portfolio
      7.3.5 Recent Developments
7.4 DSM
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Product Portfolio
      7.4.4 Business Strategies
               7.4.4.1 Strategic acquisitions
      7.4.5 Recent Developments
7.5 Fareva
      7.5.1 Company Overview
      7.5.2 Financial Overview
      7.5.3 Product Portfolio
      7.5.4 Business Strategies
               7.5.4.1 Extensive product portfolio
               7.5.4.2 Safety environment for staff
               7.5.4.3 Commitment to quality
      7.5.5 Recent Developments
7.6 Greatbatch, Inc.
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Product Portfolio
      7.6.4 Business Strategies
               7.6.4.1 Research and development
               7.6.4.2 Patents and proprietary technology
               7.6.4.3 Mergers and acquisitions
      7.6.5 Recent Developments
7.7 Lonza Group
      7.7.1 Company Overview
      7.7.2 Financial Overview
      7.7.3 Product Portfolio
      7.7.4 Business Strategies
               7.7.4.1 Investment in emerging economies
               7.7.4.2 Mergers and acquisitions
      7.7.5 Recent Developments
7.8 Patheon, Inc.
      7.8.1 Company Overview
      7.8.2 Financial Overview
      7.8.3 Product Portfolio
      7.8.4 Business Strategies
               7.8.4.1 Strategic acquisitions
               7.8.4.2 Geographical expansion of business
      7.8.5 Recent Developments
7.9 Piramal Healthcare
      7.9.1 Company Overview
      7.9.2 Financial Overview
      7.9.3 Product Portfolio
      7.9.4 Business Strategies
               7.9.4.1 Expansion of services offered
      7.9.5 Recent Developments
7.11 Symmetry Medical, Inc.
      7.11.1 Company Overview
      7.11.2 Financial Overview
      7.11.3 Product Portfolio
      7.11.4 Business Strategies
                 7.11.4.1 Diversification of product portfolio
                 7.11.4.2 Robust research and development activities
      7.11.5 Recent Developments

List of Figures
 
FIG. 1 Global Healthcare CMO Market Segmentation
FIG. 2 Global Healthcare CMO Market, by Service Type, 2012 (USD Billion)
FIG. 3 Global Pharmaceutical Contract Manufacturing Market, by Service Type, 2012 (USD Billion)
FIG. 4 Global Medical Device Contract Manufacturing Market, by Service Type, 2012 (USD Billion)
FIG. 5 Comparative Analysis: Global Healthcare CMO Market, by Geography, 2012 and 2019 (Value %)
FIG. 6 Global Healthcare CMO Market: Drivers and Restraints
FIG. 7 Porter’s Five Force Analysis: Global Healthcare CMO Market
FIG. 8 Market Attractiveness Analysis: Global Healthcare CMO Market, 2012, by Geography
FIG. 9 Heat Map Analysis: Key Market Players for the Medical Devices Contract Manufacturing Market
FIG. 10 Market Share Analysis: Global Pharmaceutical Contract Manufacturing Market, by Key Players, 2012 (Value %)
FIG. 11 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 12 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 13 Global Solid Dose Formulations Contract Manufacturing  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 14 Global Semi-solid and Liquid Dose Formulations Contract Manufacturing  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 15 Global Injectable Dose Formulations Contract Manufacturing  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 16 Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion)
FIG. 17 Global Medical Device Design Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 18 Global Device Contract Manufacturing  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 19 Global Contract Material Process Services  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 20 Global Contract Electronic Manufacturing Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 21 Global Contract Finished Products Manufacturing Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 22 Global Contract Final Goods Assembly Services  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 23 North America Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
FIG. 24 North America Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 25 North America Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 26 Europe Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
FIG. 27 Europe Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 28 Europe Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 29 Asia-Pacific Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
FIG. 30 Asia-Pacific Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 31 Asia-Pacific Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 32 RoW Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
FIG. 33 RoW Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 34 RoW Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 35 Accellent, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 36 Boehringer Ingelheim GmbH: Annual Revenue, 2010– 2012 (USD Million)
FIG. 37 Catalent Pharma Solutions, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 38 DSM: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 39 Greatbatch, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 40 Lonza Group: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 41 Patheon, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 42 Piramal Healthcare: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 43 Symmetry Medical, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: Healthcare CMO Market
TABLE 2 Global Healthcare CMO Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
TABLE 3 Global Pharmaceutical Contract Manufacturing Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
TABLE 4 Global Medical Device Contract Manufacturing Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
TABLE 5 Global Contract Manufacturing Organizations (CMO) Market, by Geography, Revenue, 2011 – 2019 (USD Billion)

Most pharmaceutical and medical devices companies are gradually outsourcing manufacturing activities to contract manufacturers in order to achieve efficiencies in cost, quality, capacity and time to market or to obtain specific expertise in particular business category, which is not available in-house. Moreover, increasing cost pressures, cost benefits and inclination of pharmaceutical companies to focus on core competencies such as R&D and marketing has created a need for outsourcing. Consequently, pharmaceutical and medical device companies are inclined toward outsourcing to concentrate on R&D and marketing of their products by minimizing the time invested in manufacturing practices. The market for contract manufacturing shows tremendous potential due to growth in the medical device industry, growing regulatory concerns and increasing demand from emerging countries.
 
This research report provides a detailed analysis of the global healthcare contract manufacturing outsourcing (CMO) market and helps in understanding the various driving factors for the growth of the market. The market overview section of this report analyzes the market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of this market. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report in order to deliver a thorough analysis of the overall competitive scenario of the global healthcare CMO market. 
 
The report discusses the healthcare CMO market based on different pharmaceutical and medical device contract manufacturing services. Pharmaceutical contract manufacturing services comprise active pharmaceutical ingredients (API) manufacturing, final dosage formulations (FDF) manufacturing and packaging. Medical device contract manufacturing services include design outsourcing, device manufacturing and final goods assembly.
 
The global healthcare CMO market has been segmented based on the parameters mentioned above. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments in terms of USD million, considering 2012 as the base year for calculation and 2011 as the historical year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has also been provided along with market size estimations.
 
The healthcare CMO market by geography has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of World (RoW). The study further offers recommendations and highlights of the market, which would be useful for existing and new market players to sustain and grow in the global healthcare CMO market. 
 
The report concludes with the company profiles section, which includes key information about the major players and market share analysis (value %) of the pharmaceutical contract manufacturing market for the year 2012. Key players profiled in this report include Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Lonza Group, Patheon, Inc., Piramal Healthcare, Accellent, Symmetry Medical, Inc. and Greatbatch, Inc.


 
 
Back To Top